Commerce Bank trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 12.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,155 shares of the exchange traded fund’s stock after selling 439 shares during the quarter. Commerce Bank’s holdings in SPDR S&P Biotech ETF were worth $312,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Tidemark LLC raised its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter worth $40,000. ORG Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the second quarter worth $40,000. ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter worth $44,000. Finally, Waldron Private Wealth LLC acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter worth $54,000.
SPDR S&P Biotech ETF Stock Up 1.2 %
NYSEARCA XBI opened at $100.00 on Thursday. The stock has a market cap of $7.62 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a fifty day moving average of $98.33 and a 200-day moving average of $96.46. SPDR S&P Biotech ETF has a fifty-two week low of $72.10 and a fifty-two week high of $105.47.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Find and Profitably Trade Stocks at 52-Week Lows
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Technology Stocks Explained: Here’s What to Know About Tech
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Pros And Cons Of Monthly Dividend Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.